Press Releases

 

09.09.10		Meditrina Pharmaceuticals, Inc. Announces Allowance of Patent for Treatment of Endometriosis
07.17.08		Meditrina Pharmaceuticals, Inc. Opens Investigational New Drug (IND) Application for Phase IIb Clinical Trial with MPI-676 in Endometriosis
02.06.08		Meditrina Pharmaceuticals, Inc. Announces Exclusive Global License Agreement with AstraZeneca
09.19.07		Meditrina Pharmaceuticals, Inc. Announces Exclusive Global Manufacturing Agreement with Pfizer Centresource (PCS) for Femathina™ (MPI-674)
04.04.07		Meditrina Pharmaceuticals, Inc. Initiates Phase II Trial and Raises $4.4m in Initial Funding